Immunotherapy-based management of metastatic clear-cell and variant RCC: What can we achieve?

Drs. Pal, Barata, McDermott, & Zhang discuss #RCC at #GU24 - https://bit.ly/RCC24YПодробнее

Immunotherapy for metastatic RCC - EMPIRE Urology Lecture SeriesПодробнее

Immune Checkpoint Inhibitors and RCC: Where Are We Now?Подробнее

What is the best front line treatment for metastatic clear cell RCC in 2018?Подробнее

KEYNOTE-564 - Immunotherapy Before Cancer Returns in Clear Cell RCCПодробнее

NIVOREN: Nivolumab in a 'real world setting' for metastatic clear-cell renal cell carcinomaПодробнее

Navigating Evolving Standards of Care in RCC: Novel Targeted and Immunotherapy OptionsПодробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

IKCS 2020: Session 3 Immunotherapy and Emerging Therapies for RCCПодробнее

Unanswered questions in the management of clear cell RCCПодробнее

Len + pembro metastatic clear cell renal cell carcinomaПодробнее

Immunotherapy for Metastatic Kidney Cancer Shows Increased SurvivalПодробнее

Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCCПодробнее

Dr. Sznol Discusses Immunotherapy in Non-Clear Cell Renal CancerПодробнее

Immunotherapy Combinations Improve Survival in Advanced Renal Cell CarcinomaПодробнее

Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationaleПодробнее

Management Round-Up: Translocation, Chromophobe, RMC, and Other SubtypesПодробнее

Immunotherapy in Renal Cell CarcinomaПодробнее

ICLIO eCourse Immunotherapies in Development for the Treatment of Metastatic RenalПодробнее